Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
about
Outcomes from unrelated donor hematopoietic stem cell transplantationAllogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis.Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survivalCombining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TrT-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCTAlpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donorsLate effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center, 1998-2006One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.The Austrian Bone Marrow Donor Registry: Providing Patients in Austria with Unrelated Donors for Transplant - a Worldwide Cooperation.Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia.A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.Emerging drugs for adult acute lymphoblastic leukaemia.Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adultsCellular therapies in acute lymphoblastic leukemiaAlternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options.Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survivalRisk assessment in haematopoietic stem cell transplantation: histocompatibility.Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant ReseAllogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia.Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.Allogeneic hematopoietic cell transplantation for adults with ALL.Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionTreatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.Clinical tolerance in allogeneic hematopoietic stem cell transplantation.The role of allogeneic hematopoietic stem cell transplantation in the therapy of patients with acute lymphoblastic leukemia.Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission.Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.Advances in haploidentical stem cell transplantation.Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse.
P2860
Q27027854-472A14B1-4710-4059-A451-E456265519E0Q30577948-0295C81F-B371-4056-8EEB-5A941CFF300DQ33816659-35EE00D9-CD2E-4659-86BE-FBDABFFC9D6DQ33862876-C18C69CC-8353-4738-9456-5D318910F3F2Q33956045-3D678740-1275-4476-985B-4D306AB266D9Q34044024-3CAEE523-6A02-4D13-9E18-603B26760B37Q34398411-62E9C637-BA73-4F52-8107-3FFDE2921D26Q34413233-80074F2B-0CC5-480C-A6A0-0397E11D568DQ34422543-C5C5CA7B-1CDF-4FC1-B60A-9C0115BB73EBQ34532041-F140936E-054B-470C-900D-370D12E5444FQ35199893-6C9034C2-E5AD-449A-A9F7-C2243AB3466FQ35640788-49A4C2A0-33FA-4D73-A899-75673AEEF0A4Q35969119-37F79145-0A60-483A-A0D2-8325B828E9CCQ35998343-B2CE2DA7-74AF-4B2C-82A9-AE0236268E67Q36123315-0EC9ABD8-A406-43BB-971F-3EEB9269CC47Q36157163-8B4BA75C-B335-47B8-98AA-C2528F9C6ACBQ36219661-56E8DD2A-F1BC-44FC-847F-FF52A2CEFC77Q36320260-CB562BD0-FE44-4F0D-8FD4-D7E92CE9AE62Q36461915-8147A28F-A86B-48C0-89FB-323FCB22AB3EQ36552098-4AFE02D8-4D0E-441F-96DB-7B628A889C96Q36557963-C240E080-D7E7-44AC-B204-B4EA2BF36B44Q36742516-1B9832DA-E369-4A77-9BBE-F2F4D130A676Q36781786-72EBCEE7-4D4E-44E5-A8E3-ABD194AA44EDQ36797744-18996426-CCC7-4BA6-8133-2719D6F8C274Q36984538-235070FD-6007-4F81-8B12-400A32008337Q36984852-5E90CE88-9543-44C0-8D5F-24232B6B9CACQ36984856-F92FEBDE-EE78-4CF6-9143-7861F424E09FQ37142892-FB2E8DD6-BBFA-43F2-A5C6-B790E82735C9Q37143670-B3AA9DC8-3E67-4E3D-8461-724F1E75DEA6Q37251043-9708905E-CFDE-49DF-842B-A85B275BBFEBQ37287039-B2A0206A-68D0-42E0-A973-94CD8A76901EQ37369934-05823029-77D3-4485-A349-FDB3F42CF5CAQ37657483-24AE4F26-5245-4F62-9D33-3B600C59266CQ37864697-2948A48A-0F0E-40A0-B21A-63592760DFBDQ37992837-C7EA4E9E-B705-41E6-9330-86818E3AFFA1Q38079288-9CF27CE1-C236-4D33-A5CD-A9865F0CC133Q38226100-A8EF72B7-7362-4652-894D-CB564A3A0DABQ39658337-14113E01-4081-404D-B99D-CD6891847B1FQ39799610-6877D132-19D2-4C46-A29B-4CC74F1BAA7CQ39835544-68B8F284-3906-400D-92A6-EDE4FE314F3F
P2860
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Outcome of allogeneic hematopo ...... t in first complete remission.
@en
Outcome of allogeneic hematopo ...... t in first complete remission.
@nl
type
label
Outcome of allogeneic hematopo ...... t in first complete remission.
@en
Outcome of allogeneic hematopo ...... t in first complete remission.
@nl
prefLabel
Outcome of allogeneic hematopo ...... t in first complete remission.
@en
Outcome of allogeneic hematopo ...... t in first complete remission.
@nl
P2093
P356
P1476
Outcome of allogeneic hematopo ...... t in first complete remission.
@en
P2093
Arnold Ganser
Axel A Fauser
Axel R Zander
Bernd Hertenstein
Christoph Scheid
Dieter Hoelzer
Hans Martin
Joachim Kienast
Ludwig Kraut
Martin Bornhaeuser
P304
P356
10.1200/JCO.2004.07.130
P407
P577
2004-07-01T00:00:00Z